Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 12;19(18):11466.
doi: 10.3390/ijerph191811466.

Association between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study

Affiliations

Association between 3-Year Repetitive Isolated Hematuria and eGFR Deterioration in an Apparently Healthy Population: A Retrospective Cohort Study

Mami Ishida et al. Int J Environ Res Public Health. .

Abstract

Microscopic hematuria is being increasingly recognized as a major indicator of kidney deterioration. Persistent hematuria may better detect estimated glomerular filtration rate (eGFR) deterioration and potential glomerulonephritis. We conducted a retrospective cohort study to investigate the associations between persistent hematuria: the frequency or consistency of positive dipstick hematuria defined by the preceding 3 years urinalyses, and eGFR deterioration over 5 years and abnormal urinalyses suggesting potential glomerulonephritis (hematuria 1+ or higher, 2+ or higher, proteinuria, and hematuria and proteinuria) 5 years later, among adult participants with positive dipstick hematuria at baseline in a large-scale Japanese health checkup setting (n = 2104). There was no significant association between persistent hematuria and eGFR deterioration over 5 years. The higher the frequency of preceding hematuria, the greater the RR of hematuria 5 years later; RRs of hematuria with preceding thrice, twice, or once hematuria were 3.64 [95% CI, 3.11-4.25], 2.97 [95% CI, 2.52-3.51], or 1.91 [95% CI, 1.58-2.30] for "hematuria 1+ or higher," and 7.13 [95% CI, 5.17-9.83], 4.26 [95% CI, 3.02-6.02], or 2.23 [95% CI, 1.52-3.27] for "hematuria 2+ or higher". The presence of both hematuria and proteinuria 5 years later was only associated with preceding thrice hematuria (RR: 2.35 [95% CI, 1.37-4.03]). In conclusion, persistent hematuria for 3 years was associated with hematuria and proteinuria that were suggesting glomerulonephritis, but not associated with eGFR deterioration over 5 years. Multiple dipstick urinalyses over years can add some values to detect potential glomerulonephritis as an early sign of chronic kidney diseases.

Keywords: IgA nephropathy; chronic glomerulonephritis; chronic kidney disease; health checkup; persistent hematuria; screening.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient timeline showing timing of enrolment and data collection. Participants with dipstick hematuria at baseline (April 2011 through March 2013) with available three annual dipstick results for the previous 3 years and serum creatinine results at baseline and at the 5-year mark were included in the study. Outcomes were assessed according to estimated glomerular filtration rate (eGFR) and urinalyses.
Figure 2
Figure 2
(a): Patterns of persistent hematuria defined by the frequency of hematuria. (b): Patterns of persistent hematuria defined by the consistency of hematuria. Three or more consecutive hematuria was defined as persistent hematuria and is shown by gray area.
Figure 2
Figure 2
(a): Patterns of persistent hematuria defined by the frequency of hematuria. (b): Patterns of persistent hematuria defined by the consistency of hematuria. Three or more consecutive hematuria was defined as persistent hematuria and is shown by gray area.
Figure 3
Figure 3
Participants flow.
Figure 4
Figure 4
eGFR reduction for 5 years according to the frequency of hematuria. * Adjusted for age, sex, BMI, hypertension, diabetes mellitus, dyslipidemia, hyperuricemia, baseline GFR.
Figure 5
Figure 5
Prevalence of four urinary findings suggesting glomerulonephritis in four groups that is stratified by the frequency of hematuria during three years before the index health checkup. (a): hematuria 1+ or higher: 1+, 2+ or 3+; (b): hematuria 2+ or higher: 2+ or 3+; (c): proteinuria; (d): hematuria and proteinuria.
Figure 6
Figure 6
Associations between the frequency of hematuria and four urinary findings suggesting glomerulonephritis 5 years later, expressed as odds ratios; multiple logistic regression analysis. Reference is the group whose frequency of hematuria is never.

Similar articles

Cited by

References

    1. Jha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y.-M., Yang C.-W. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013;382:260–272. doi: 10.1016/S0140-6736(13)60687-X. - DOI - PubMed
    1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.-y. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N. Engl. J. Med. 2004;351:1296–1305. doi: 10.1056/NEJMoa041031. - DOI - PubMed
    1. Mills K.T., Xu Y., Zhang W., Bundy J.D., Chen C.-S., Kelly T.N., Chen J., He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88:950–957. doi: 10.1038/ki.2015.230. - DOI - PMC - PubMed
    1. GBD 2015 Mortality and Causes of Death Collaborators Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1. - DOI - PMC - PubMed
    1. Bikbov B., Purcell C.A., Levey A.S., Smith M., Abdoli A., Abebe M., Adebayo O.M., Afarideh M., Agarwal S.K., Agudelo-Botero M., et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709–733. doi: 10.1016/S0140-6736(20)30045-3. - DOI - PMC - PubMed

Publication types